References and Notes
For reviews of the Suzuki coupling, see:
1a
Miyaura N.
Suzuki A.
Chem. Rev.
1995,
95:
2457
1b
Miyaura N.
Adv. Organomet. Chem.
1998,
6:
187
1c
Miyaura N.
Top. Curr. Chem.
2002,
219:
11
For reviews of the Miyaura borylation, see:
2a
Ishiyama T.
Miyaura N.
J. Organomet. Chem.
2000,
611:
392
2b
Ishiyama T.
Miyaura N.
Chem. Rec.
2004,
3:
271
3a
Murata M.
Watanabe S.
Masuda Y.
J. Org. Chem.
1997,
62:
6458
3b
Murata M.
Oyama T.
Watanabe S.
Masuda Y.
J. Org. Chem.
2000,
65:
164
4a
Murata M.
Watanabe S.
Masuda Y.
Tetrahedron Lett.
2000,
41:
5877
4b
Murata M.
Oyama T.
Watanabe S.
Masuda Y.
Synthesis
2000,
778
4c
Murata M.
Oyama T.
Watanabe S.
Masuda Y.
Synth. Commun.
2002,
32:
2513
5
Baudoin O.
Guénard D.
Guéritte F.
J. Org. Chem.
2000,
65:
9268
6
Doux M.
Mézailles N.
Melaimi M.
Ricard L.
LeFloch P.
Chem. Commun.
2002,
1566
7
Wolan A.
Zaidlewicz M.
Org. Biomol. Chem.
2003,
1:
3274
8
Broutin P.-E.
Čerña I.
Campaniello M.
Leroux F.
Colobert F.
Org. Lett.
2004,
6:
4419
9
Murata M.
Buchwald SL.
Tetrahedron
2004,
60:
7397
10
Hamann BC.
Hartwig JF.
J. Am. Chem. Soc.
1998,
120:
7369
11
t-Bu-DPEphos (L8) was prepared from diphenylether and (t-Bu)2PCl by a similar procedure for the preparation of DPEphos. See: Kranenburg M.
Vanderburgt YEM.
Kamer PCJ.
van Leeuwen PWNM.
Goubitz K.
Fraanje J.
Organometallics
1995,
14:
3081
12 For a review of the palladium-catalyzed couplings of aryl chlorides, see: Littke AF.
Fu GC.
Angew. Chem. Int. Ed.
2002,
41:
4176
13 Compound 3d: 1H NMR (CDCl3): δ = 1.35 (s, 12 H), 7.47 (t, J = 7.9 Hz, 1 H), 7.73 (d, J = 7.9 Hz, 1 H), 8.01 (d, J = 7.9 Hz, 1 H), 8.09 (s, 1 H). 13C NMR (CDCl3): δ = 24.81, 84.46, 111.95, 118.79, 128.36, 134.37, 138.37, 138.73. HRMS (EI): m/z calcd for C13H16BNO2 [M+]: 229.1274; found: 229.1312. IR (KBr): 2228 cm-1.
Compound 3f: 1H NMR (CDCl3): δ = 1.36 (s, 12 H), 7.61 (d, J = 7.9 Hz, 2 H), 7.92 (d, J = 7.9 Hz, 2 H). 13C NMR (CDCl3): δ = 24.98, 84.25, 124.29 (q, J = 4 Hz), 124.13 (q, J = 272 Hz), 132.80 (q, J = 32 Hz), 135.21. HRMS (EI): m/z calcd for C13H16BF3O2 [M+]: 272.1196; found: 272.1229.
Compound 3g: 1H NMR (CDCl3): δ = 1.21 (s, 12 H), 7.30-7.50 (m, 8 H), 7.71 (d, J = 7.8 Hz, 1 H). 13C NMR (CDCl3): δ = 24.55, 83.69, 126.23, 126.79, 127.74, 128.92, 129.08, 130.03, 134.40, 143.19, 147.46. HRMS (EI): m/z calcd for C18H21BO2 [M+]: 280.1635; found: 280.1629.
Compound 3i: 1H NMR (CDCl3): δ = 1.21 (d, J = 6.7 Hz, 6 H), 1.25 (d, J = 6.7 Hz, 12 H), 1.37 (s, 12 H), 2.84 (sept, J = 6.7 Hz, 1 H), 2.98 (sept, J = 6.7 Hz, 2 H), 6.93 (s, 2 H). 13C NMR (CDCl3): δ = 24.01, 24.55, 24.98, 34.00, 34.49, 83.61, 119.63, 149.72, 151.86. HRMS (EI): m/z calcd for C21H35BO2 [M+]: 330.2730; found: 330.2773.
Compound 3j: 1H NMR (CDCl3): δ = 1.32 (s, 12 H), 2.86 (d, J = 5.5 Hz, 3 H), 3.92 (br s, 1 H), 6.58 (d, J = 8.5 Hz, 2 H), 7.65 (d, J = 8.5 Hz, 2 H). 13C NMR (CDCl3): δ = 24.79, 30.22, 83.13, 111.38, 136.26, 151.74. HRMS (EI): m/z calcd for C13H20BNO2 [M+]: 233.1587; found: 233.1611.
IR (KBr): 3425, 3401, 3375 cm-1.